Detail akcie Xwell Rg online

Business Summary: XWELL, Inc. is a global wellness holding company. The Company operates through four segments: XpresSpa, XpresTest, Naples Wax Center and Treat. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresCheck segment, in partnership with the Centers for Disease Control and Prevention (CDC) and Ginkgo Biosecurity, conducts biosurveillance monitoring in its airport locations. XpresTest’s HyperPointe business provides a range of service and support options for its customers, including technical support services and advanced services. The Naples Wax Center segment operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products. The Treat segment is a wellness brand that provides access to wellness services for travelers at on-site centers.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Xwell Inc revenues decreased 17% to $22.1M. Net loss applicable to common stockholders increased 6% to $9.8M. Revenues reflect XpresTest segment decrease of 40% to $6.4M. Higher net loss reflects Corporate and other segment loss increase of 54% to $10.4M, Naples Wax segment loss increase from $174K to $1M, XpresTest segment income decrease of 15% to $3.8M.